128 related articles for article (PubMed ID: 32283322)
21. Differences in telomerase expression by the CD1a+ cells in Langerhans cell histiocytosis reflect the diverse clinical presentation of the disease.
da Costa CE; Egeler RM; Hoogeboom M; Szuhai K; Forsyth RG; Niesters M; de Krijger RR; Tazi A; Hogendoorn PC; Annels NE
J Pathol; 2007 Jun; 212(2):188-97. PubMed ID: 17447723
[TBL] [Abstract][Full Text] [Related]
22. Garp as a therapeutic target for modulation of T regulatory cell function.
Shevach EM
Expert Opin Ther Targets; 2017 Feb; 21(2):191-200. PubMed ID: 28001437
[TBL] [Abstract][Full Text] [Related]
23. Does CD1a Expression Influence T Cell Function in Patients With Langerhans Cell Histiocytosis?
Mitchell J; Kannourakis G
Front Immunol; 2021; 12():773598. PubMed ID: 34956202
[TBL] [Abstract][Full Text] [Related]
24. Detection of clonal lymphoid receptor gene rearrangements in langerhans cell histiocytosis.
Chen W; Wang J; Wang E; Lu Y; Lau SK; Weiss LM; Huang Q
Am J Surg Pathol; 2010 Jul; 34(7):1049-57. PubMed ID: 20551822
[TBL] [Abstract][Full Text] [Related]
25. Langerhans cell histiocytosis: fascinating dynamics of the dendritic cell-macrophage lineage.
Egeler RM; van Halteren AG; Hogendoorn PC; Laman JD; Leenen PJ
Immunol Rev; 2010 Mar; 234(1):213-32. PubMed ID: 20193021
[TBL] [Abstract][Full Text] [Related]
26. Altered Populations of Unconventional T Cell Lineages in Patients with Langerhans Cell Histiocytosis.
Mitchell J; Kvedaraite E; von Bahr Greenwood T; Henter JI; Pellicci DG; Berzins SP; Kannourakis G
Sci Rep; 2018 Nov; 8(1):16506. PubMed ID: 30405183
[TBL] [Abstract][Full Text] [Related]
27. Aberrant chemokine receptor expression and chemokine production by Langerhans cells underlies the pathogenesis of Langerhans cell histiocytosis.
Annels NE; Da Costa CE; Prins FA; Willemze A; Hogendoorn PC; Egeler RM
J Exp Med; 2003 May; 197(10):1385-90. PubMed ID: 12743170
[TBL] [Abstract][Full Text] [Related]
28. Regulatory T-cell expansion in oral and maxillofacial Langerhans cell histiocytosis.
Zhang C; Gao J; He J; Liu C; Lv X; Yin X; Deng Y; Lu Z; Tian Z
Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Nov; 130(5):547-556. PubMed ID: 32988807
[TBL] [Abstract][Full Text] [Related]
29. CSF1R Is Required for Differentiation and Migration of Langerhans Cells and Langerhans Cell Histiocytosis.
Lonardi S; Scutera S; Licini S; Lorenzi L; Cesinaro AM; Gatta LB; Castagnoli C; Bollero D; Sparti R; Tomaselli M; Medicina D; Calzetti F; Cassatella MA; Facchetti F; Musso T; Vermi W
Cancer Immunol Res; 2020 Jun; 8(6):829-841. PubMed ID: 32238382
[TBL] [Abstract][Full Text] [Related]
30. Expression of cellular adhesion molecules in Langerhans cell histiocytosis and normal Langerhans cells.
de Graaf JH; Tamminga RY; Kamps WA; Timens W
Am J Pathol; 1995 Oct; 147(4):1161-71. PubMed ID: 7573361
[TBL] [Abstract][Full Text] [Related]
31. Regulatory T cells in atopic dermatitis: epidermal dendritic cell clusters may contribute to their local expansion.
Szegedi A; Baráth S; Nagy G; Szodoray P; Gál M; Sipka S; Bagdi E; Banham AH; Krenács L
Br J Dermatol; 2009 May; 160(5):984-93. PubMed ID: 19222459
[TBL] [Abstract][Full Text] [Related]
32. Monokine expression in Langerhans' cell histiocytosis and sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease).
Foss HD; Herbst H; Araujo I; Hummel M; Berg E; Schmitt-Gräff A; Stein H
J Pathol; 1996 May; 179(1):60-5. PubMed ID: 8691347
[TBL] [Abstract][Full Text] [Related]
33. Langerhans' cell histiocytosis (histiocytosis X): immunophenotype and growth fraction.
Hage C; Willman CL; Favara BE; Isaacson PG
Hum Pathol; 1993 Aug; 24(8):840-5. PubMed ID: 7690735
[TBL] [Abstract][Full Text] [Related]
34. Use of FoxP3 expression to identify regulatory T cells in healthy dogs and dogs with cancer.
Biller BJ; Elmslie RE; Burnett RC; Avery AC; Dow SW
Vet Immunol Immunopathol; 2007 Mar; 116(1-2):69-78. PubMed ID: 17224188
[TBL] [Abstract][Full Text] [Related]
35. CD4+ CD25+ Foxp3+ regulatory T cells protect against T cell-mediated fulminant hepatitis in a TGF-beta-dependent manner in mice.
Wei HX; Chuang YH; Li B; Wei H; Sun R; Moritoki Y; Gershwin ME; Lian ZX; Tian Z
J Immunol; 2008 Nov; 181(10):7221-9. PubMed ID: 18981144
[TBL] [Abstract][Full Text] [Related]
36. Study of liver-targeted regulatory T cells in hepatitis B and C virus in chronically infected patients.
Miyaaki H; Zhou H; Ichikawa T; Nakao K; Shibata H; Takeshita S; Akiyama M; Ozawa E; Miuma S; Eguchi K
Liver Int; 2009 May; 29(5):702-7. PubMed ID: 18673437
[TBL] [Abstract][Full Text] [Related]
37. Langerhans-cell histiocytosis 'insight into DC biology'.
Laman JD; Leenen PJ; Annels NE; Hogendoorn PC; Egeler RM
Trends Immunol; 2003 Apr; 24(4):190-6. PubMed ID: 12697451
[TBL] [Abstract][Full Text] [Related]
38. Evidence that Langerhans cells in adult pulmonary Langerhans cell histiocytosis are mature dendritic cells: importance of the cytokine microenvironment.
Tazi A; Moreau J; Bergeron A; Dominique S; Hance AJ; Soler P
J Immunol; 1999 Sep; 163(6):3511-5. PubMed ID: 10477625
[TBL] [Abstract][Full Text] [Related]
39. Alteration in frequency and function of CD4⁺CD25⁺FOXP3⁺ regulatory T cells in patients with immune thrombocytopenic purpura.
Arandi N; Mirshafiey A; Jeddi-Tehrani M; Shaghaghi M; Sadeghi B; Abolhassani H; Sharifian RA; Rahiminejad MS; Aghamohammadi A
Iran J Allergy Asthma Immunol; 2014 Apr; 13(2):85-92. PubMed ID: 24338252
[TBL] [Abstract][Full Text] [Related]
40. Defective alloantigen-presenting capacity of 'Langerhans cell histiocytosis cells'.
Yu RC; Morris JF; Pritchard J; Chu TC
Arch Dis Child; 1992 Nov; 67(11):1370-2. PubMed ID: 1471889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
